Abstract
Marine sponges are shown to be abundant sources of bioactive peptides. Structurally they include linear peptides, peptide lactones, cyclic peptides, and depsipeptides, with number of residues ranging from two to 48. Some of them have highly modified structural features with nonproteinogenic amino acid or hydroxy acid residues, while others have those with minimal alterations from the common ribosomal peptides. The structural characteristics, biogenesis, biological activity, and the issue of producing symbiotic organisms of nonribosomal peptides reported since 1993 are described in the order of structural types.
Keywords: nonribosomal peptides, marine sponges, bioactive peptides, peptide lactones, depsipeptides, nonproteinogenic amino acid, ribosomal peptides
Current Organic Chemistry
Title: Nonribosomal Peptides from Marine Sponges
Volume: 7 Issue: 10
Author(s): Shigeki Matsunaga and Nobuhiro Fusetani
Affiliation:
Keywords: nonribosomal peptides, marine sponges, bioactive peptides, peptide lactones, depsipeptides, nonproteinogenic amino acid, ribosomal peptides
Abstract: Marine sponges are shown to be abundant sources of bioactive peptides. Structurally they include linear peptides, peptide lactones, cyclic peptides, and depsipeptides, with number of residues ranging from two to 48. Some of them have highly modified structural features with nonproteinogenic amino acid or hydroxy acid residues, while others have those with minimal alterations from the common ribosomal peptides. The structural characteristics, biogenesis, biological activity, and the issue of producing symbiotic organisms of nonribosomal peptides reported since 1993 are described in the order of structural types.
Export Options
About this article
Cite this article as:
Matsunaga Shigeki and Fusetani Nobuhiro, Nonribosomal Peptides from Marine Sponges, Current Organic Chemistry 2003; 7 (10) . https://dx.doi.org/10.2174/1385272033486648
DOI https://dx.doi.org/10.2174/1385272033486648 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Macrophage Migration Inhibitory Factor (MIF) Tautomerase Inhibitors as Potential Novel Anti-Inflammatory Agents: Current Developments
Current Medicinal Chemistry Bone Seeking Radiopharmaceuticals for Palliation of Pain in Cancer Patients with Osseous Metastases
Anti-Cancer Agents in Medicinal Chemistry New Therapeutic Strategies in Perinatal Stroke
Current Drug Targets - CNS & Neurological Disorders Recent Developments in the Synthesis of Antitumor-active Glycyrrhetinic Acid Derivatives
Mini-Reviews in Organic Chemistry The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Formulation Strategies and Particle Engineering Technologies for Pulmonary Delivery of Biopharmaceuticals
Current Pharmaceutical Design Adiposity and Alzheimers Disease
Current Alzheimer Research Nenatal Drug Induced Nephrotoxicity : Old and Next Generation Biomarkers for Early Detection and Management of Neonatal Drug-Induced Nephrotoxicity, with Special Emphasis on uNGAL and on Metabolomics
Current Medicinal Chemistry Vitamin D Supplementation: A Promising Approach for the Prevention and Treatment of Strokes
Current Drug Targets The Dramatic Role of IFN Family in Aberrant Inflammatory Osteolysis
Current Gene Therapy Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Current Pharmaceutical Design Relevance of the Vascular Effects of Insulin in the Rationale of its Therapeutical Use
Cardiovascular & Hematological Disorders-Drug Targets Triggering of Toll-like Receptors in Old Individuals. Relevance for Vaccination
Current Pharmaceutical Design The Proteomic Approach in the Development of Prognostic Biomarkers in Atherothrombosis
Recent Patents on Cardiovascular Drug Discovery Role of Membrane Transporters and Metabolizing Enzymes in Ocular Drug Delivery
Current Drug Metabolism Prospects for Gene Therapy of Osteopetrosis
Current Gene Therapy TWEAK as a Biomarker
Recent Patents on Biomarkers Prognostic and Predictive Molecular Markers in Cutaneous Malignant Melanoma: The First Step Toward Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Ionic Liquids: A New Strategy in Pharmaceutical Synthesis
Mini-Reviews in Organic Chemistry